Glumetza Tablet, Film Coated, Extended Release
Pricing Report NDC 68012-002-13

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Glumetza (NDC 68012-002-13) is $49.48362 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 21, 2018.

As a a human prescription drug provided by Santarus, Inc., this medication is distributed in a 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$49.48362
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Mar 21, 2018
Billable Units
100 EA
Estimated Package Price
$4,948.36
Data Status
As of Jan 30, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
68012-002-13
Description
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $9.09140 (Effective: Dec 19, 2018)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2014, the NADAC wholesale price for (NDC ) has moved within a range of $5.50145 to $50.09070 per EA. Over this 3 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.5015 - $50.0907
Market Volatility
810.50% Variance
Latest Trend
1.21%
Date Unit Price Unit Source Method Rate
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2018 $49.48362 EAC/I - Chain or Independent PharmacyCode 4B - Brand
May 18, 2016 $50.09070 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 18, 2016 $50.09070 EAC/I - Chain or Independent PharmacyCode 2B - Brand
May 18, 2016 $50.09070 EAC/I - Chain or Independent PharmacyCode 2B - Brand
May 18, 2016 $50.09070 EAC/I - Chain or Independent PharmacyCode 4B - Brand
May 18, 2016 $50.09070 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jul 31, 2015 $49.63176 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jul 31, 2015 $49.63176 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jul 31, 2015 $49.63176 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jun 18, 2015 $33.08784 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jun 18, 2015 $33.08784 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jun 17, 2015 $5.51464 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 20, 2014 $5.53347 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 20, 2014 $5.53347 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 20, 2014 $5.53347 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jul 23, 2014 $5.50145 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: June 17, 2026